Kiniksa Pharmaceuticals International reported third quarter 2026 results, with basic earnings per share from continuing operations of US$0.61 and diluted earnings per share of US$0.56, compared with ...
Source LinkKiniksa Pharmaceuticals International reported third quarter 2026 results, with basic earnings per share from continuing operations of US$0.61 and diluted earnings per share of US$0.56, compared with ...
Source Link
Comments